Skip to Main Content

Paper Details

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
1
2023
Author NameAffiliation
Chaitanya BandlamudiMemorial Sloan Kettering Cancer Center
Hira RizviMemorial Sloan Kettering Cancer Center
Jianjun ZhangMD Anderson Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
Charles M RudinMemorial Sloan Kettering Cancer Center
Gregory J RielyMemorial Sloan Kettering Cancer Center
  • 1 - 6

Datasets

Release 1.2